Novel technology for angiogram-based physiology measurement.
Cathworks develops devices for the interventional cardiology market and is focused on improving the utilization of coronary angiography data to ratify measurement-based medicine in the cath lab. CathWorks is a privately-held Israeli company established in 2013. It is supported by a dominant strategic partner as well as leading venture capital firms in the medical devices arena.
